2014
DOI: 10.5935/0004-2749.20140045
|View full text |Cite
|
Sign up to set email alerts
|

Ophthalmologic findings in hepatitis C patients treated with pegylated interferon α-2b and ribavirin

Abstract: Purpose: To identify the effect of pegylated interferon α-2b and ribavirin treatment in the ocular fundus examination, visual acuity, and visual field. Methods: Prospective observational study was performed at the Hepatology Clinic of São José Regional Hospital and at the Vitreoretinal Department at the Sadalla Amin Ghanem Eye Hospital in patients with chronic hepatitis C before and during treatment with pegylated interferon α-2b together with ribavirin. Results: Six (37.5%) of 16 patients developed retinopath… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 21 publications
(26 reference statements)
0
2
0
Order By: Relevance
“…Case reports of episcleritis are associated with interferon alpha-2b in the treatment of head and neck mucosal melanoma 106. There are also reports of non-arteritic anterior ischaemic optic neuropathy, neuromyelitis optica, optic neuritis, retinopathy, cystoid macular oedema, Vogt–Koyanagi–Harada disease, abducens palsy, oculomotor nerve palsy, glaucoma and retinal vein thrombosis reported in patients treated with interferon alpha 107–129…”
Section: Resultsmentioning
confidence: 99%
“…Case reports of episcleritis are associated with interferon alpha-2b in the treatment of head and neck mucosal melanoma 106. There are also reports of non-arteritic anterior ischaemic optic neuropathy, neuromyelitis optica, optic neuritis, retinopathy, cystoid macular oedema, Vogt–Koyanagi–Harada disease, abducens palsy, oculomotor nerve palsy, glaucoma and retinal vein thrombosis reported in patients treated with interferon alpha 107–129…”
Section: Resultsmentioning
confidence: 99%
“…And as no epidemiolo gical studies have described the incidence of these pathologies, such patients should be examined and monitored, particularly in the event of complaints or adver se events (84) . Tsolakos et al suggest that patients with pre-existing retinopathy, especially patients with hypertension and diabetes, should be monitored monthly during the course of hepatitis C treatment (74,85,86) . Recommended eye examinations include visual acuity, slit-lamp biomicroscopy, and ophthalmoscopy (87) .…”
Section: Ocular Changes Associated With Ifn and Ribavirin Treatmentmentioning
confidence: 99%